Our findings showed that DHA may be a potential therapeutic agent to overcome the limitations of CBP by reducing BMI-1, VEGF and VEGFR2 levels, which are associated with CSCs and tumor neovascularization and are crucial for chemoresistance. Here, VEGFA is linked to neoplasm.